Status:
COMPLETED
An Exploratory Open Label Study of Adjunctive L-lysine Treatment in Patients With Schizophrenia
Lead Sponsor:
Göteborg University
Collaborating Sponsors:
Stanley Medical Research Institute
Conditions:
Schizophrenia
Eligibility:
All Genders
23-56 years
Phase:
NA
Brief Summary
The objective of the present study was to investigate the possibility of using L-lysine, an amino acid that occurs naturally in food and which interferes with nitric oxide (NO) production, for the tre...
Eligibility Criteria
Inclusion
- a stable phase of illness
- a stable dose of antipsychotic medication
- no other major medical conditions or other psychiatric diagnosis
- normal admission laboratory tests and vital signs
Exclusion
- substance abuse, apart from smoking
Key Trial Info
Start Date :
September 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00996242
Start Date
September 1 2007
End Date
March 1 2009
Last Update
October 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahlgrenska Univeristy Hospital
Gothenburg, Sweden, SE 405 30